Author:
Rocha Martinez Tania Leme da
Reference38 articles.
1. Clinical perspectives on primary and secondary prevention of coronary atherosclerosis;Deedvania;Med Clin North Am,1995
2. Martens LL, Guibert R. Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease. Clin Ther.1994;16(6):1052-1062.
3. Plans Rubió P, Rovira Forns J. Cost-effectiveness of pharmacologic treatments for the reduction of blood lipids. Med Clin (Barc).1995;105(9):327-333.
4. The cost-effectiveness of different blood-cholesterol-lowering strategies in the prevention of coronary heart disease;Kinlay;Aust J Public Health,1994
5. Keys A. Seven Countries: A multivariate analysis of death and coronary heart disease. Cambridge: Harvard University Press; 1980. p. 381.